会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • STENT AND STENT DELIVERY SYSTEM WITH IMPROVED DELIVERABILITY
    • 具有改进的可交付性的STENT和STENT交付系统
    • US20110190864A1
    • 2011-08-04
    • US13014632
    • 2011-01-26
    • James B. McClainDouglas TaylorDavid Enscore
    • James B. McClainDouglas TaylorDavid Enscore
    • A61F2/84A61F2/82
    • A61F2/958A61F2/0077A61F2002/826A61F2250/003
    • Stent delivery systems having improved deliverability comprising an elongate member having an inflation lumen and a guidewire lumen therein; a balloon having an interior that is in fluid communication with the inflation lumen; and a stent comprising a coating mounted on the balloon. Methods for making stent delivery systems having improved deliverability. Methods for delivering two stent delivery systems concurrently through a guiding catheter, each stent delivery system comprising elongate member having an inflation lumen and a guidewire lumen therein, a balloon having an interior that is in fluid communication with the inflation lumen, and a stent comprising a coating mounted on the balloon. Stent coatings may comprise a pharmaceutical agent at least a portion of which is in crystalline form.
    • 具有改善的输送能力的支架输送系统包括具有充气腔和其中的导丝腔的细长构件; 具有与膨胀腔流体连通的内部的气囊; 以及支架,其包括安装在气囊上的涂层。 用于制备具有改善的输送性的支架输送系统的方法。 用于通过引导导管同时递送两个支架输送系统的方法,每个支架输送系统包括具有充气腔和其中的导丝腔的细长构件,具有与充气腔流体连通的内部的球囊,以及支架, 涂层安装在气球上。 支架涂层可以包含至少一部分为结晶形式的药剂。
    • 10. 发明申请
    • DRUG DELIVERY MEDICAL DEVICE
    • 药物递送医疗设备
    • US20100239635A1
    • 2010-09-23
    • US12729580
    • 2010-03-23
    • James B. McClainDouglas TaylorJohn Neet
    • James B. McClainDouglas TaylorJohn Neet
    • A61K9/00A61K38/22A61P43/00
    • A61L31/16A61L27/16A61L27/34A61L29/085A61L29/16A61L31/10A61L2300/602A61L2300/608A61L2300/63A61L2420/08A61M25/0045
    • Provided is a coated implantable medical device, comprising: a substrate; and a coating disposed on said substrate, wherein said coating comprises at least one polymer and at least one pharmaceutical agent in a therapeutically desirable morphology and/or at least one active biological agent and optionally, one or more pharmaceutical carrying agents; wherein substantially all of pharmaceutical agent and/or active biological agent remains within said coating and on said substrate until the implantable device is deployed at an intervention site inside the body of a subject and wherein upon deployment of said medical device in the body of said subject a portion of said pharmaceutical agent and/or active biological agent is delivered at said intervention site along with at least a portion of said polymer and/or a at least a portion of said pharmaceutical carrying agents.
    • 提供一种涂覆的可植入医疗装置,包括:基底; 以及设置在所述基底上的涂层,其中所述涂层包含至少一种聚合物和至少一种治疗上需要的形态和/或至少一种活性生物试剂和任选的一种或多种药物载体的药剂; 其中基本上所有的药剂和/或活性生物制剂都保留在所述涂层内和所述衬底上,直到可植入装置部署在受试者身体内部的介入部位,并且其中在将所述医疗装置部署在所述受试者的身体中时 所述药剂和/或活性生物剂的一部分与所述聚合物的至少一部分和/或所述药物载体的至少一部分在所述介入部位递送。